Yu J, Zhou K, Wang J, Mao L, et al. Preliminary efficacy, tolerability, and safety analysis of Darolutamide for metastatic castration?resistant prostate cancer: a single-center, open-label study. Urol Int 2024 Oct 15:1-13. doi: 10.1159/000541929.
PMID: 39406197